Encephalon #35 arrives November 7, 2007
Posted by Johan in Abnormal Psychology, Links, Neuroscience.add a comment
The latest issue of Neuroscience blogging carnival Encephalon is now online over at Primate Diaries.
My two picks of the issue would be two stories on Autism: Not Exactly Rocket Science reports on an experiment that is consistent with the ever-controversial idea that autism is linked with a deficient mirroring system. Also, Medopedia explores some possible reasons why people with Asperberger’s, that is, high-functioning Autism, frequently experience sleep disorders.
In Defense of Electroconvulsive Therapy October 30, 2007
Posted by Johan in Abnormal Psychology, Applied, Emotion.2 comments

The TED talks website contains material for a hundred posts, but a video posted earlier today hits particularly close to home. In this talk, Sherwin Nuland, a surgeon turned writer, gives an authoritative and unexpectedly personal account of the history of electroconvulsive therapy (ECT), sometimes known as electric shock therapy. The talk is only about 20 minutes, and gets very interesting around the 7 minute mark where Nuland describes how ECT once saved his life, as he puts it.
If the general public could be accused of placing too much trust in antidepressant medication, the reverse is certainly true of ECT. Ask anyone about electric shock therapy, and they’ll conjure up horror stories, and associations with frontal lobotomy. This is unfair, since there is some evidence that ECT actually works for depression.
The research on this issue has produced mixed results and plenty of controversy, as reviews by Challiner and Griffiths (2000) and by the UK ECT Review Group (2003) outline. However, there is no shortage of positive findings, and this in itself is rather remarkable, when you consider the patients that receive it. Since ECT is considered rather drastic, it is only really considered for patients who are severely depressed, and who have failed to respond to antidepressants. In other words, ECT is usually only considered in cases with the worst possible prognosis, so the fact that it does seem to help at times is quite powerful in itself, given the probability of spontaneous recovery from such conditions. That being said, a read of the ECT literature is unsatisfying. Because ECT is viewed as such a dramatic intervention (even in the absence of evidence that it causes long-term harm), it has rarely been tested on “normal” depressives in random control trials.
As Challiner and Griffiths (2000) outline, a lot of the popular conceptions of ECT are untrue. It doesn’t cause massive spasms – muscle relaxants are administered. It is not going to be a traumatic experience, because you will be put under a general anaesthetic. Although bilateral administration of ECT has been associated with memory loss, this does not appear to happen with unilateral administration, where both electrodes are kept on one side of the head (as shown in the picture at the top).
There is another issue with ECT, which I think bothers practitioners than clients. In the case of antidepressants, we at least know how they work, although it is far from clear why boosting synaptic Serotonin levels should work, given the weak evidence for a lack of Serotonin in depression. With ECT, there are no convincing explanations for either the how or the why. Psychiatrists stumbled upon ECT in the happy days of wild experimentation that preceded Ethics Committees, without much of a theory. It is quite embarrassing that even to this day, we can say so little about what this treatment does, or indeed if it even does anything at all – a pertinent question given the claim on Wikipedia that 1 million people receive ECT each year worldwide.
If I ever developed a severe depression, I would try ECT before antidepressants. Unlike antidepressants, the effects of ECT can be instantaneous, and there are no long-term side-effects, nor any withdrawal symptoms when the treatment ends. Since the treatment is extremely safe when administered properly, there is really very little to lose.
References
Challiner, V., and Griffiths, L. (2000). Electroconvulsive therapy: a review of the literature. Journal of Psychiatric and Mental Health Nursing, 7, 191-198.
The UK ECT Review Group. (2003). Efficacy and safety of electroconvulsive therapy in depressive disorders: a systemic review and meta-analysis. Lancet, 361, 799-808.
What do you know, additives really do cause hyperactivity September 29, 2007
Posted by Johan in Abnormal Psychology, Developmental Psychology, Psychopharmacology.add a comment

This post is about a very different E211.
A few months back, the menu from of a local Chinese takeaway caught my eye. Apart from the lengthy questionnaire, which customers could complete to receive £2 off (pretty smart way of gathering customer data for a non-chain takeaway), the menu also made numerous claims that all products were absolutely free of additives, including the ubiquitous Monosodium glutamate (MSG) and colourings. This is a good thing, the menu claimed, because additives cause ADHD in children.
My initial reaction was to silently promise myself never to order from that take-away, just as I wouldn’t buy my aspirin in a pharmacy that sells magnet bracelets (although this is a hard rule to follow in the UK, where homeopaths are funded by the NHS), or books from the Christian Science Reading Room. However, it turns out these guys weren’t far off the mark, as a recent study from The Lancet shows (by the way and for the record, this is apparently by no means the first study to report this).
McCann et al (2007) recruited two groups of kids (ages 4 and 8-9), who received two additive cocktails and placebo in different sequences, all disguised in juice. While the exact makeup of the mixes varied, both featured Sodium benzoate (aka, e211). For reference, the contents of one of these mixes was about equivalent to the food colouring present in 2 56-gram packets of sweet for the 3-year-olds, so the doses were not far outside of what a kid might consume on a daily basis.
Using a range of behavioural and peer-rating measures, McCan et al were able to show that on the whole, one of the mixes was associated with increased hyperactive behaviour in the three-year-olds, while both mixes were associated with increase hyperactive behaviour in the 8-9-year-olds. So keeping your kids away from food colouring may not be such a bad idea, after all.
I think this is a beautiful finding, because it’s just the sort of result that I would dismiss as spurious, had it been obtained by an association study, e.g., “hyperactive kids consume more additives than non-hyper kids” (a topic I touched upon recently). It is quite easy to suppose that, for instance, hyperactive kids like sweet, sugary foods with lots of additives better than others, but apparently that isn’t the whole story. This is a prime example of the power of the randomised, double-blind control trial in ruling out alternative accounts.
So either the Chinese takeaway is lucky enough that a belief they held for the wrong reason happens to be true, or someone on staff reads medical journals. I know where to get my Sichuan chicken next time, anyhow.
References
McCann, D., Barrett, A., Cooper, A., Crumpler, D., Dalen L., Grimshaw, K.,Kitchin E., Lok, K., Porteous, L., Prince E., Sonuga-Barke E., Warner, J.O., and Stevenson, J. (In Press – don’t you hate how medics always squeeze in half the department as authors? It’s almost as bad as the human genome project publications. Anyhow, back to the reference). Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. The Lancet.
Detecting genetic disorders with 3d face scans September 16, 2007
Posted by Johan in AI, Abnormal Psychology, Applied, Behavioural Genetics, Developmental Psychology, Face Perception.add a comment

Following on from last week’s post on smile measuring software, The Scotsman (via Gizmodo) reports on the work by Hammond and colleagues at UCL, who are developing 3d face scans as a quick, inexpensive alternative to genetic testing. This is not as crazy as it sounds at first since it is known that in a number of congenital conditions, the hallmark behavioural, physiological or cognitive deficits are also (conveniently) accompanied by characteristic appearances. The classic example of this is Down syndrome, which you need no software to recognise. More examples appear in the figure above, where you can compare the characteristic appearances of various conditions to the unaffected face in the middle.
Hammond’s software can be used to identify 30 congenital conditions, ranging from Williams syndrome (a sure topic of a future post) to Autism, according to the Scotsman. I know of no facial characteristics of autism, so I would take that part of the story with a grain of salt. The system claims an accuracy rate of over 90 percent, which is not conclusive, but certainly good enough to inform a decision to carry out genetic tests that are. The UCL press release gives some more information about how the software works:
The new method compares a child’s face to similarly aged groups of individuals with known conditions and selects which condition looks the most similar. In order to do this, collections of 3D face images of children and adults with the same genetic condition had to be gathered, as well as controls or individuals with no known genetic condition.
It really is too bad that the software uses 3d images – those cameras are neither cheap nor ubiquitous, which somewhat defeats the point of using this software as an affordable alternative to (or initial screening for) genetic testing. I can’t help but wonder if it wouldn’t be possible to achieve similar accuracy using normal portraits. If you can tell how much someone is smiling in a photo, you should be able to pick up on that extra chromosome…
